Our technology is a platform

〉Designed to work for any disease that elicits an immune response, including

  • infectious diseases
  • neurologic diseases
  • cancers

 

〉Our technology quantifies RNA of

  • immune system biomarkers
  • pathogens
  • therapeutic targets

 

〉Works on all current genetic testing laboratory equipment

Multiple clinically useful applications

Personalized Diagnostics

Companion Diagnostics

Therapeutic Targets

AI-based Applications

Peer-reviewed scientific abstract

 

• FBB Biomed’s proprietary enrichment method amplifies intronic and intergenic sequences

• We accurately identified gene sequences that correlate with clinically reported flares in 19 out of 19 samples

• Our pre-clinical study found multiple gene sequences that define severity in RRMS